Organovo Holdings Reports Director Changes and Compensatory Arrangements

Ticker: VIVS · Form: 8-K · Filed: Nov 22, 2024 · CIK: 1497253

Organovo Holdings, Inc. 8-K Filing Summary
FieldDetail
CompanyOrganovo Holdings, Inc. (VIVS)
Form Type8-K
Filed DateNov 22, 2024
Risk Levellow
Pages4
Reading Time5 min
Key Dollar Amounts$0.001
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, officer-changes, director-changes

TL;DR

Organovo Holdings filed an 8-K detailing director changes, new officers, and compensation plans.

AI Summary

Organovo Holdings, Inc. filed an 8-K on November 20, 2024, reporting on the departure of directors, election of new directors, appointment of officers, and compensatory arrangements. The filing also covers matters submitted to a vote of security holders and includes financial statements and exhibits. The company is incorporated in Delaware and its fiscal year ends on March 31.

Why It Matters

Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing is a routine corporate disclosure of board and officer changes and compensation, with no immediate financial or operational risks indicated.

Key Players & Entities

  • Organovo Holdings, Inc. (company) — Registrant
  • Delaware (jurisdiction) — State of Incorporation
  • November 20, 2024 (date) — Date of earliest event reported

FAQ

What specific items are being reported in this 8-K filing?

This 8-K filing reports on the departure of directors or certain officers, the election of directors, the appointment of certain officers, compensatory arrangements of certain officers, submission of matters to a vote of security holders, and financial statements and exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on November 20, 2024.

What is the company's state of incorporation?

Organovo Holdings, Inc. is incorporated in Delaware.

What is the company's fiscal year end?

Organovo Holdings, Inc.'s fiscal year ends on March 31.

What is the company's business address?

The company's business address is 11555 Sorrento Valley Road, Suite 100, San Diego, California 92121.

Filing Stats: 1,240 words · 5 min read · ~4 pages · Grade level 12.1 · Accepted 2024-11-22 08:05:29

Key Financial Figures

  • $0.001 — nge on which registered Common Stock, $0.001 par value ONVO The Nasdaq Stock Mar

Filing Documents

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. The Company held the Annual Meeting on November 20, 2024. Of the 15,365,826 shares of the Company's common stock, par value $0.001 per share (the "Common Stock"), issued and outstanding as of the September 23, 2024 record date, 6,626,882 shares, or 43.12%, constituting a quorum, were represented at the Annual Meeting either virtually or by proxy. A description of each proposal voted upon at the Annual Meeting is described in detail in the Proxy Statement. Set forth below is a brief description of each proposal voted upon at the Annual Meeting and the voting results with respect to each proposal. (1) Election of Directors . The Company's stockholders elected Alison Tjosvold Milhous and Vaidehi Joshi as Class I directors, each to hold office until the 2027 Annual Meeting of Stockholders and until her respective successors is elected and qualified. The following table shows the tabulation of the votes cast "For" and "Withheld" for each of Ms. Milhous and Ms. Joshi as well as the "Broker Non-Votes" submitted for this proposal: Director For Withheld Broker Non-Votes Alison Tjosvold Milhous 3,437,284 272,550 2,917,048 Director For Withheld Broker Non-Votes Vaidehi Joshi 3,485,882 223,952 2,917,048 (2) Ratification of Auditors . The Company's stockholders ratified the appointment of Rosenberg Rich Baker Berman P.A. as the Company's independent registered public accounting firm for the fiscal year ending March 31, 2025, with the approval of 89.25% of the votes cast. The following table shows the tabulation of the votes cast "For" and "Against" this proposal as well as the "Abstentions" submitted for this proposal: For Against Abstentions 5,839,178 702,605 85,099 (3) Advisory Vote on the Compensation of Named Executive Officers . The Company's stockholders, on a non-binding, advisory basis, approved the compensation of the Company's named executive officers as

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. Exhibit No. Description 10.1 Organovo Holdings, Inc. – Amended and Restated 2022 Equity Incentive Plan. 104 Cover Page Interactive Data File, formatted in Inline Extensible Business Reporting Language (iXBRL).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 22, 2024 ORGANOVO HOLDINGS, INC. By: /s/ Keith Murphy Keith Murphy Executive Chairman

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.